Safety of Single-Dose Oral Cefaclor Prophylaxis in Transperineal Prostate Biopsy

Single-dose oral cefaclor prophylaxis in TPB appears to be safe, with no serious post-procedural infections observed. Its effectiveness in frail or high-risk patients requires confirmation in future large prospective studies.

Authors

Haruka Miyai
Masaya Nishihata
Sohei Iwagami (ORCID: https://orcid.org/0009-0000-1841-1121)

Institutions

Kishiwada Tokushukai Hospital (JP)

Publication Details

Journal: Research and Reports in Urology
Published: 2026-02-01
DOI: https://doi.org/10.2147/rru.s586606
Primary Topic: Prostate Cancer Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety of Single-Dose Oral Cefaclor Prophylaxis in Transperineal Prostate Biopsy

Haruka Miyai, Masaya Nishihata, Sohei Iwagami

Feb 1, 2026

Research and Reports in Urology

Prostate Cancer Diagnosis and Treatment

article

Safety of Single-Dose Oral Cefaclor Prophylaxis in Transperineal Prostate Biopsy

Haruka Miyai, Masaya Nishihata, Sohei Iwagami

February 1, 2026article en

Abstract

Research and Reports in UrologyVol. Volume 18

Kishiwada Tokushukai Hospital (JP)

Good health and well-being

Openalex Percentile: Top 69%

Prostate Cancer Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.